检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]中山大学附属江门医院 [2]江门市中心医院肿瘤科,广东江门529070 [3]江门市中心医院肝胆外科,广东江门529070 [4]江门市中心医院介入治疗科,广东江门529070
出 处:《现代生物医学进展》2009年第21期4184-4186,4082,共4页Progress in Modern Biomedicine
摘 要:肝癌的治疗之所以困难,一是耐药,二是无法防治癌的转移复发。对不能切除的肝癌,半个世纪的努力无大进展,现在人们对肝癌的认识仍然停留在原有阶段,肝癌研究热点的手术治疗、介入治疗、众多局部微创消融治疗,以及三维适形放射治疗等,其目标均聚焦主体肿瘤治疗,而肝内侵袭转移治疗依然被忽视。目前有效防治肝内播散和转移方法尚无共识。本文对肝癌转移复发相关因素进行综述。The difficulty in the treatment of primary liver cancer(PLC) ,first because drug-fast,the second is metastasis and recurrence of PLC can not prevent and cure. There is no significant progress of efforts for half a century to unresectable PLC,now people's understanding of PLC is still remained on the original stage,the research of hotspot includeing the surgical treatment of liver cancer,interventional therapy,many local minimally traumatic ablation treatment,and three-dimensional conformal radiation therapy,their objectives were direct focusing to the main tumor treatment,while treatment of intrahepatic invade and metastasis are still neglected. At present there is no consensus on transfer method for the effective prevention and treatment of intrahepatic spread. This article is summarized related factors of metastasis and recurrence of PLC.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222